Disease Overview：Artificial Insemination（AI）
Artificial insemination (AI) is a foundational assisted reproductive technology (ART) used to treat infertility caused by factors such as mild male factor infertility (e.g., oligozoospermia or asthenozoospermia), cervical mucus hostility, unexplained infertility, or ovulatory disorders. The procedure involves the direct placement of processed, high-motility sperm into the uterine cavity—typically via intrauterine insemination (IUI)—timed to coincide with ovulation, either natural or induced through controlled ovarian stimulation. Unlike in vitro fertilization (IVF), AI does not involve oocyte retrieval or embryo culture, making it less invasive and more cost-efficient for select patient profiles. Success rates vary by indication, age, and ovarian reserve but generally range from 10–20% per cycle in optimally selected candidates. Rigorous pre-treatment evaluation—including semen analysis, hormonal profiling, tubal patency assessment (e.g., hysterosalpingography), and endometrial assessment—is essential to determine eligibility and maximize outcomes.
China offers distinct advantages for international patients seeking AI: its reproductive medicine centers are staffed by board-certified reproductive endocrinologists with extensive clinical experience and adherence to international protocols (e.g., ESHRE/ASRM guidelines). Leading hospitals deploy state-of-the-art sperm processing labs, real-time ultrasound-guided ovulation monitoring, and integrated electronic medical records for precise cycle tracking. With over 500,000 annual ART cycles performed nationwide, China reports consistently high IUI success benchmarks—particularly among women under 35—and maintains rigorous quality accreditation through the National Health Commission. Treatment costs are typically 40–60% lower than in the US, UK, or Australia, without compromising clinical standards or laboratory integrity. As a dedicated medical tourism agency, we facilitate seamless access to top-tier fertility hospitals across Beijing, Shanghai, and Guangzhou—handling everything from initial eligibility screening and hospital referrals to visa support, multilingual coordination, transparent all-inclusive pricing, and post-procedure follow-up. Our role ensures continuity of care, cultural navigation, and evidence-based decision-making tailored to each patient’s reproductive goals.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Artificial Insemination (AI)
Non-Surgical / Conservative / Medication-Based Options
*Target Criteria*: Unexplained infertility, mild male factor (motility >30%, count >10 million/mL), cervical factor, or ovulatory disorders with intact tubal patency and normal ovarian reserve (AMH ≥1.2 ng/mL, AFC ≥5).
- •Ovulation Induction + Timed AI (Clomiphene or Letrozole)
- Cycle monitoring (2–3 transvaginal ultrasounds + serum E2/P4): $120–$180 - Ovulation trigger (hCG injection): $25–$35 - Sperm preparation (washed donor or partner semen): $110–$150 - Intrauterine insemination (IUI) procedure: $130–$190 *Total per cycle*: $330–$520
- •Gonadotropin-Stimulated AI (for suboptimal response to oral agents)
- Enhanced monitoring (4–5 ultrasounds + 3–4 hormone assays): $210–$300 - All other components as above *Total per cycle*: $620–$920
Surgical / Procedural / Interventional Options
*Eligibility Criteria*: Confirmed patent fallopian tubes (via HSG or laparoscopy), absence of moderate–severe endometriosis (rASRM Stage I–II only), no uterine cavity distortion (normal hysteroscopy), BMI <35 kg/m².
- •Diagnostic Hysteroscopy + Tubal Cannulation (if proximal tubal occlusion suspected)
- Procedure (day surgery, local + sedation): $420–$680 - Pathology (endometrial biopsy if indicated): $35–$55
- •Laparoscopic Tubal Patency Confirmation + Adhesiolysis (Stage I–II endometriosis)
- Laparoscopy (including dye test, adhesiolysis, ablation): $1,250–$1,850 - Post-op recovery + 1 follow-up visit: $45–$65
Special / Complex Condition Options
- •Donor Sperm AI (for azoospermia, genetic risk, or single women)
- Cryopreserved donor sperm vial (imported or domestic bank): $280–$440 - AI procedure + prep: $130–$190 *Total per cycle*: $630–$940
- •Frozen-Thawed Sperm AI (post-vasectomy reversal or cryopreservation)
- Standard Selection Guide
- •<35 years, no comorbidities, budget <$500/cycle: Start with Clomiphene/Letrozole + AI ($330–$520) — 3-cycle success rate ~35%.
- • years, mild male factor, budget $600–$900/cycle: Gonadotropin-stimulated AI ($620–$920) — higher pregnancy rate (40–45% over 3 cycles).
- •Tubal concerns or unexplained failure after 3 AI cycles: Proceed to diagnostic hysteroscopy/laparoscopy ($420–$1,850) before advancing to IVF.
- •Azoospermia or genetic carrier status: Donor sperm AI ($630–$940) is first-line; avoid surgical sperm retrieval unless TESE is indicated for obstructive cases.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Artificial Insemination Medical Vacation Packages
Curated transparent all-inclusive packages combining Artificial Insemination treatment with China top medical destinations:
